- Editor's PickNicole Sinclair•yesterday
On Monday, Medivation (MDVN), which owns Xtandi, confirmed it was being acquired by Pfizer (PFE) for $14 billion. This comes just months after Sanofi (SNY) approached Medivation in a hostile deal, going public with its offer and beginning a process to replace the company’s board. Sanofi lost out on its bid to Pfizer, which was willing to pay up and fold Medivation into its oncology franchise.
- Investor's Business Daily•yesterday
Pfizer's Medivation buyout agreement has put an M&A spotlight on BioMarin, Incyte, Vertex and other drug companies.
- Investor's Business Daily•5 days ago
Would it help your portfolio to know what Fidelity's 200 stock and stock-plus-bond mutual funds bought and sold in Q2?
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Ask||101.15 x 100|
|Day's Range||100.68 - 102.34|
|52wk Range||75.90 - 136.97|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-89.06|
|Avg Vol (3m)||1,399,850|
|Dividend & Yield||N/A (N/A)|